1) Mg_xZn_(1-x)O hexagonal nanocrystals
Mg_xZn_(1-x)O六方纳米晶
1.
The objective of this work was to understand the locations of Eu ion doped in Mg_xZn_(1-x)O nanocrystals and the role of Eu on the microstructure and optical properties of doped Mg_xZn_(1-x)O hexagonal nanocrystals.
XPS结果表明Mg_xZn_(1-x)O六方纳米晶已经形成,并且纳米晶中既有Eu2+又有Eu3+,但它们的含量都很低。
2) Mg_xZn_(1-x)O thin film
Mg_xZn_(1-X)O纳米薄膜
3) Mg_xZn_(1-x)O nanopowder
Mg_xZn_(1-x)O纳米粉体
1.
Mg_xZn_(1-x)O nanopowders were prepared by Sol-Gel method and Mg_xZn_(1-x)O ceramic
采用溶胶凝胶法制备了Mg_xZn_(1-x)O纳米粉体,并利用该粉体制备了Mg_xZn_(1-x)O陶瓷,采用XRD、分光光度仪和荧光光谱仪表征了纳米粉体和陶瓷的结构、发光性能和吸收、透过特性。
4) cubic Mg_xZn_(1-x)O films
立方相Mg_xZn_(1-x)O薄膜
5) Mg_xZn_(1-x)O alloy films
Mg_xZn_(1-x)O合金
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条